Incyte (INCY) Gross Profit Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,488.21% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 19.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.23% |
| Dec 31, 2025 | 27.10% |
| Sep 30, 2025 | 20.45% |
| Jun 30, 2025 | 17.54% |
| Mar 31, 2025 | 19.49% |
| Dec 31, 2024 | 15.54% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | 9.12% |
| Mar 31, 2024 | 9.06% |
| Dec 31, 2023 | 8.77% |
| Sep 30, 2023 | 11.74% |
| Jun 30, 2023 | 2.97% |
| Mar 31, 2023 | 8.87% |
| Dec 31, 2022 | 5.93% |
| Sep 30, 2022 | -0.57% |
| Jun 30, 2022 | 28.92% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | 8.74% |
| Sep 30, 2021 | 31.86% |
| Jun 30, 2021 | 1.99% |
| Mar 31, 2021 | 6.34% |
| Dec 31, 2020 | 37.65% |
| Sep 30, 2020 | 12.42% |
| Jun 30, 2020 | 30.80% |
| Mar 31, 2020 | 13.87% |
| Dec 31, 2019 | 8.99% |
| Sep 30, 2019 | 22.75% |
| Jun 30, 2019 | 0.78% |
| Mar 31, 2019 | 30.51% |
| Dec 31, 2018 | 19.02% |
| Sep 30, 2018 | 18.19% |
| Jun 30, 2018 | 62.21% |
| Mar 31, 2018 | -1.38% |
| Dec 31, 2017 | 37.44% |
| Sep 30, 2017 | 44.22% |
| Jun 30, 2017 | 30.89% |
| Mar 31, 2017 | 43.42% |
| Dec 31, 2016 | 31.05% |
| Sep 30, 2016 | 38.81% |
| Jun 30, 2016 | 49.25% |
| Mar 31, 2016 | 64.72% |
| Dec 31, 2015 | 92.67% |
| Sep 30, 2015 | -9.27% |
| Jun 30, 2015 | 57.68% |
| Mar 31, 2015 | 74.40% |
| Dec 31, 2014 | 25.43% |
| Sep 30, 2014 | 132.94% |
| Jun 30, 2014 | -2.09% |
| Mar 31, 2014 | 26.36% |
| Dec 31, 2013 | -14.81% |
| Sep 30, 2013 | 40.53% |
| Jun 30, 2013 | 17.33% |
| Mar 31, 2013 | 96.10% |
| Dec 31, 2012 | 293.73% |
| Sep 30, 2012 | 260.27% |
| Jun 30, 2012 | 415.31% |
| Mar 31, 2012 | 15.62% |
| Dec 31, 2011 | -66.37% |
| Sep 30, 2011 | 0.29% |
| Jun 30, 2011 | -66.22% |
| Mar 31, 2011 | 82.16% |